Meikang Biology (300439.SZ): Heparin-binding protein test kit (chemiluminescence immunoassay) obtained a medical device registration certificate

Zhitong Finance App News, Meikang Biotech (300439.SZ) announced that recently, the company's holding subsidiary Jiangxi Meikang Shengde Biotechnology Co., Ltd. (hereinafter referred to as “Jiangxi Meikang”) obtained the “People's Republic of China Medical Device Registration Certificate (in vitro diagnostic reagent)” issued by the Jiangxi Drug Administration, involving the product: “Heparin binding protein test kit (chemiluminescence immunoassay)”.

The acquisition of the “Registration Certificate” mentioned above has enriched the variety of the company's product line in the field of in vitro diagnostic chemiluminescence segments, which is conducive to further enhancing the company's core competitiveness and market expansion capabilities, and will have a positive impact on the company's future operations.